PDS Research Committee CME: Pearls and Perils in Dermatologic Research
Camille Berenguer-Angeles, MD, FPDS
Event: PDS- CME
Date: January 29, 2020
Venue: Lung Center Auditorium, Lung Center of the Philippines
Moderator: Bryan K. Guevara
Welcome Remarks: Camille Angeles
Case Presenters / Lecturers:
- Charm Castillo
- Vanessa Carpio
- Czarina Pineda-Chavez
- Mara Evangelista-Huber
The first PDS-CME activity for the year 2020 was hosted by the PDS Research Committee. To start off the meeting, Dr. Bryan Guevara, our dashing moderator, introduced Dr. Charmaine Castillo, PDS Secretary, who presented this year’s Consultant staff and Residents of the PDS Institutions. Next on center stage was Dr. Vanessa Carpio, Chair of the PDS Health Information System Task Force who enumerated the current goals of HIS, namely monitoring (1) disease trends for policy and decision-making for public health; (2) health care operations; and (3) patient logs for accreditation of training institutions and residents. Dr. Carpio also showed the top 10 diseases logged in for the year 2019. Total number of patients seen for 2019 was 54850, based on the census of the following Institutions: EAMC, JRMMC, OMMC, RITM, SCFI, with UST, UERM,SLMC contributing to an extent. The following institutions stopped recording their census in HIS since 2018: MMC, SPMC, PGH.
The main event of the CME started with Dr. Czarina Pineda-Chavez giving us a lecture filled with pearls on research study designs. Keeping it simple and easy to understand, she focused on differentiating the 2 main types of study designs: descriptive and analytical; and discussed those that were more commonly used in clinical research. Adding a bit of fun, the audience were able to participate by answering questions via a game-based online learning platform (Kahoot!). To the winners of the game – Dr. Felina Dy (1st place), Dr. R-jay Agbon (2nd place), both residents of SLMC, and Dr. Crystal Retuya from SCF – kudos to you! Our next speaker, Dr. Mara Evangelista-Huber passionately delivered a timely, interesting lecture focused on the perils of misleading and misrepresented research entitled, “Bad data, Bad science.” She discussed 3 red flags when hearing about a scientific research or breakthrough: 1) There is not enough data (particularly in supplements or cosmeceuticals where laboratory data is not yet supported with clinical data), 2) There are too many tests done on the data (multiplicity), and 3) The data cannot be replicated. Dr. Huber closed the lecture reminding us to “Trust, but verify”, an important task for every evidence-based dermatologist. The lectures during this CME event help us to determine the appropriate study design suited for our research question, and encourages us to appraise and analyze published clinical data. One must realize that, as one of the pillars of the PDS, research plays an important role in delivering the best care and management to our patients – making us truly the DermAuthority.
Top 10 diseases based on new cases seen in the PDS institutions from January 1 to December 31, 2019.
|Diagnosis||New Cases||Proportion of Cases|
|3||Dermatophytosis of the skin*||2567||4.7%|
|7||Allergic Contact Dermatitis||1181||2.2%|
|9||Lichen Simplex Chronicus||999||1.8%|
* Dermatophytosis of the skin includes tinea corporis, tinea cruris, tinea manuum, tinea pedis, tinea faciale, tinea imbricata, tinea nigra, tinea incognito, and tinea circinata.
Top 10 diseases based on new and existing cases seen in the PDS Institutions from January 1 to December 31, 2019.
|Diagnosis||No. of Cases||Proportion of Cases|
|3||Dermatophytosis of the skin*||3194||5.8%|
|7||Allergic Contact Dermatitis||1405||2.6%|
|9||Lichen Simplex Chronicus||1253||2.3%|
*Dermatophytosis of the skin includes tinea corporis, tinea cruris, tinea manuum, tinea pedis, tinea faciale, tinea imbricata, tinea nigra, tinea incognito, and tinea circinata.